Health Condition 1: O997- Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium Health Condition 2: O997- Diseases of the skin and subcutaneous tissue complicating pregnancy, childbirth and the puerperium
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Patients undergoing elective cesarean section under spinal anaesthesia. 2)Patients belonging to ASA physical status Grade I, Grade II. 3)Patients who have given informed and written consent.
Exclusion criteria
Exclusion criteria: 1)Patients allergic to study drug 2)Patients with any contraindication to spinal procedure 3)Failed spinal anaesthesia in patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess whether Nalbuphine(0.8mg) causes pruritus as an intrathecal adjuvant to 0.5% hyperbaric Bupivacaine similar to FentanylTimepoint: Immediately after intrathecal administration during spinal anaesthesia and then every 1 hour till 24hours from the time of administration. | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the sensory & motor block characteristics & duration of post operative analgesia of Nalbuphine & Fentanyl as intrathecal adjuvants to 0.5% hyperbaric Bupivacaine.Timepoint: Immediately after intrathecal administration of spinal anaesthesia, 5, 10 minutes to look for onset of sensory & motor block. 1 hour, 2 hours, 3 hours, 6hours, 12hours to look for duration of sensory & motor block & for duration of post operative analgesia. | — |
Countries
India
Contacts
Senior Consutant Anaesthesiology ,Central Hospital Maligaon ,N F Railway